Boston Scientific's Patent Suit Against J&J Heads To Jury

Law360, New York (July 1, 2005, 12:00 AM EDT) -- In the last of three lawsuits between Boston Scientific Corp. and Johnson & Johnson Inc. over patent rights to cardiovascular stent technology, the jury convened Friday to begin deliberations in Boston Scientific’s patent lawsuit against J&J.

Boston Scientific, which lost two earlier trials to J&J over the lucrative technology, claims J&J's Cypher drug-eluting stent infringes its patents.

In closing arguments on Thursday, Patterson Belknap partner Gregory Diskant told the jury that Johnson & Johnson didn’t infringe Boston Scientific’s patents, which he said were invalid.

“You don't...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.